NIH whistleblower, GLP-1 telehealth, microbiome: Morning Rounds
Telehealth has been on the rise in recent months, with the FDA closely monitoring the marketing practices of telehealth companies offering compounded weight loss drugs. However, it’s important to note that these companies do not directly prescribe medications; that task falls to doctors at affiliated medical groups. A recent analysis by STAT’s Katie Palmer reveals that a small number of medical groups supply doctors to a large portion of telehealth companies.
Out of over 70 telehealth companies cautioned by the FDA in the past six months, at least 30% have public affiliations with just four nationwide medical groups. While the FDA lacks jurisdiction over these groups, individual prescribers are regulated by state medical boards. As awareness grows regarding the complex structure of direct-to-consumer prescribing, there could be lasting implications for both patients and prescribers.
In other health news, a study published in Nature Medicine suggests that the composition of an individual’s gut microbiome may be altered for up to 8 years following a course of oral antibiotics. The research, conducted in Sweden with nearly 15,000 participants, found significant reductions in gut microbiome diversity for those who had taken antibiotics within the past year. Specific antibiotics like clindamycin, fluoroquinolones, and flucloxacillin showed the strongest associations with gut changes.
Meanwhile, Jenna Norton, a former program officer at the NIH, faced repercussions after speaking out about the Trump administration’s impact on science and research. Despite being put on administrative leave and labeled a “radical leftist,” Norton stands by her decision to voice her concerns. She believes that scientists should not shy away from politics, a sentiment echoed in a recent essay by Science magazine editor Holden Thorp.
On a different note, momentum is building for the establishment of an office of men’s health at the federal health department. Lawmakers have introduced bills for the past 25 years, with the latest iteration garnering bipartisan support and endorsement from the American Medical Association. The initiative aims to address the unique health needs of men and promote longer, healthier lives.
In the realm of neurology, the American Association of Neurology recently released guidance on incorporating wearable devices like smart watches and fitness trackers into patient care. While these devices have the potential to enhance data collection and improve patient outcomes, the evidence for their utility in neurology remains limited. The guidance highlights the benefits of wearable technology in monitoring vital signs and tracking movement for individuals with neurological conditions.
As technology continues to reshape healthcare, it’s crucial for medical professionals to stay informed and adapt to emerging trends. From telehealth advancements to gut microbiome research, the landscape of medicine is constantly evolving. Stay updated with STAT’s newsletter for the latest insights and developments in health and medicine.
